NCT01833832View on ClinicalTrials.gov

Surgery and Heated Chemotherapy for Adrenocortical Carcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

April 12, 2013

Primary Completion Date

August 9, 2018

Study Completion Date

August 9, 2018

Conditions
Adrenocortical CarcinomaPeritoneal Carcinomatosis
Interventions
DRUG

Cisplatin

Patients who are successfully debulked will then undergo hyperthermic intraperitoneal chemotherapy (HIPEC) with cisplatin.

PROCEDURE

Cytoreductive surgery

Patients will undergo cytoreductive surgery to achieve a Completeness of Cytoreduction Score (CC) of 0 or 1.

DRUG

sodium thiosulfate

sodium thiosulfate will be given to limit the toxicity of cisplatin

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT01833832 - Surgery and Heated Chemotherapy for Adrenocortical Carcinoma | Biotech Hunter | Biotech Hunter